CCL18 and cancer: Meng et al., through an IHC analysis of the CCL18 expression in samples from 62 patients that underwent PDAC resection, found that patients with CCL18 expression in either cancer cells or mesenchymal cells had significantly shorter overall survival as opposed to patients without expression in either cell type [85].